Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Equity Income (2022 - 2025)

Historic Equity Income for Agilon Health (AGL) over the last 4 years, with Q3 2025 value amounting to $13.1 million.

  • Agilon Health's Equity Income rose 54157.3% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 19502.48%. This contributed to the annual value of $15.0 million for FY2024, which is 907.88% down from last year.
  • Latest data reveals that Agilon Health reported Equity Income of $13.1 million as of Q3 2025, which was up 54157.3% from $5.4 million recorded in Q2 2025.
  • Agilon Health's Equity Income's 5-year high stood at $14.7 million during Q3 2023, with a 5-year trough of -$8.0 million in Q4 2023.
  • Moreover, its 4-year median value for Equity Income was $5.7 million (2024), whereas its average is $5.0 million.
  • In the last 5 years, Agilon Health's Equity Income tumbled by 21063.89% in 2023 and then soared by 54157.3% in 2025.
  • Over the past 4 years, Agilon Health's Equity Income (Quarter) stood at $7.2 million in 2022, then crashed by 210.64% to -$8.0 million in 2023, then skyrocketed by 66.4% to -$2.7 million in 2024, then surged by 587.49% to $13.1 million in 2025.
  • Its last three reported values are $13.1 million in Q3 2025, $5.4 million for Q2 2025, and $12.7 million during Q1 2025.